Stock Events

Stock Events

Shattuck Labs 

$6.43
0
+$0.59+10.1% Today

Statistics

Day High
6.43
Day Low
5.8
52W High
-
52W Low
-
Volume
76
Avg. Volume
-
Mkt Cap
406.88M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q3 2025
Q4 2025
Next
-0.15
-0.14
-0.13
-0.12
Expected EPS
-0.14487
Actual EPS
N/A

Financials

-1,318.13%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
11.44MRevenue
-150.82MNet Income

Analyst Ratings

$9.00Average Price Target
The highest estimate is 15.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
75%
Hold
25%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow STTK.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics is involved in gene editing, a cutting-edge area of biotech that competes with Shattuck Labs' focus on developing innovative immunotherapies.
Intellia Therapeutics
NTLA
Mkt Cap1.35B
Intellia Therapeutics is another key player in the CRISPR/Cas9 gene editing space, directly competing with Shattuck Labs in the field of genomic medicine.
Editas Medicine
EDIT
Mkt Cap276.95M
Editas Medicine operates in the genome editing sector, making it a competitor to Shattuck Labs as both seek to harness advanced technologies for therapeutic development.
Allogene Therapeutics
ALLO
Mkt Cap275.13M
Allogene Therapeutics focuses on allogeneic CAR T-cell therapies, competing with Shattuck Labs in the broader immunotherapy and cell therapy market.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences, with its acquisition of Kite Pharma and focus on cell therapies for cancer, competes with Shattuck Labs in the oncology and immunotherapy space.
Novartis
NVS
Mkt Cap237.61B
Novartis, through its innovative healthcare solutions including CAR T-cell therapy Kymriah, competes in the same immunotherapy space as Shattuck Labs.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb, with a strong portfolio in immuno-oncology and cellular therapy, is a major competitor to Shattuck Labs in the development of cancer treatments.
Merck
MRK
Mkt Cap214.76B
Merck & Co., known for its blockbuster cancer drug Keytruda, competes with Shattuck Labs in the immunotherapy and oncology market.

About

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Show more...
CEO
ISIN
US82024L1035

Listings

XNAS
US
STTK
BOATS
BOATS
STTK.BOATS

0 Comments

Share your thoughts

FAQ

What is Shattuck Labs stock price today?▼
The current price of STTK.BOATS is $6.43 USD — it has increased by +10.1% in the past 24 hours. Watch Shattuck Labs stock price performance more closely on the chart.
What is Shattuck Labs stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Shattuck Labs stocks are traded under the ticker STTK.BOATS.
What is Shattuck Labs market cap?▼
Today Shattuck Labs has the market capitalization of 406.88M
When is the next Shattuck Labs earnings date?▼
Shattuck Labs is going to release the next earnings report on May 13, 2026.
What were Shattuck Labs earnings last quarter?▼
STTK.BOATS earnings for the last quarter are -0.12 USD per share, whereas the estimation was -0.14 USD resulting in a +11.88% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Shattuck Labs revenue for the last year?▼
Shattuck Labs revenue for the last year amounts to 11.44M USD.
What is Shattuck Labs net income for the last year?▼
STTK.BOATS net income for the last year is -150.82M USD.
When did Shattuck Labs complete a stock split?▼
Shattuck Labs has not had any recent stock splits.